Fosså S D, Aabyholm T, Vespestad S, Norman N, Ous S
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo.
Eur Urol. 1993;23(1):172-6. doi: 10.1159/000474589.
During the last 14 years repeated sperm cell analyses and serum hormone analysis were done regularly in patients with testicular cancer before and after treatment. The summarized results are hereby reported. The sperm cell count was highly impaired in 60-70% of testicular cancer patients evaluated 1-4 weeks after unilateral orchidectomy before further treatment. However, improvement of the exocrine gonadal function was regularly observed during the following 2-3 years, provided there were normal or only slightly elevated pre-treatment FSH levels. Standard irradiation and cytotoxic treatment (abdominal radiotherapy 30-40 Gy; < or = 4 cycles of cisplatin-based chemotherapy) delayed this recovery by about one year. Higher doses of chemotherapy or combined irradiation/chemotherapy reduced the chances of rapid improvement of the exocrine gonadal function. Unilateral retroperitoneal lymph node dissection resulted in a slight reduction of the post-treatment ejaculatory volume, even in patients with preserved antegrade ejaculation.
在过去14年中,对睾丸癌患者在治疗前后定期进行重复的精子细胞分析和血清激素分析。现将总结结果报告如下。在接受进一步治疗前单侧睾丸切除术后1 - 4周评估的睾丸癌患者中,60 - 70%的患者精子细胞计数严重受损。然而,在接下来的2 - 3年中,只要治疗前促卵泡激素(FSH)水平正常或仅略有升高,外分泌性腺功能通常会有所改善。标准放疗和细胞毒性治疗(腹部放疗30 - 40 Gy;≤4周期基于顺铂的化疗)使这种恢复延迟了约一年。更高剂量的化疗或联合放疗/化疗降低了外分泌性腺功能快速改善的几率。单侧腹膜后淋巴结清扫术导致治疗后射精量略有减少,即使是在具有顺行射精功能的患者中也是如此。